A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
Clinical trial NCT03823391 · COMPLETED
Trial details
- NCT number
- NCT03823391
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-27
- Primary completion
- 2020-04-08
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.